Experts highlight early ischemic signs on CT that can estimate onset of stroke

Experts recently revealed non-contrast CT image findings that could help clinicians determine when the timing of stroke onset is unknown. 

A new paper published this week in the European Journal of Radiology found associations between early ischemic signs (EIS) and onset to imaging time (OTI) that they believe could help to guide providers in making treatment decisions for patients who suffer an acute ischemic stroke

“Onset to imaging (OTI) time is a crucial factor in determining treatment eligibility for acute ischemic stroke patients, since the treatments are time-dependent,” corresponding author Laura M. van Poppel, of Biomedical Engineering and Physics at Amsterdam UMC - Academic Medical Center, and co-authors commented. “Patients with an unknown OTI time are often excluded from treatment, or advanced imaging is needed, which is not widely and readily available.” 

Experts analyzed 61 studies that touched on the topic of EIS and OTI for their research. Through this they found that hyperdense artery sign prevalence decreased after six hours since stroke onset had passed. As OTI continued to increase, so did hypodensity frequency. Mass effect was also found to be more commonly associated with later OTI times as well. 

Of note, the authors shared that the studies that quantified hypodensity on baseline non-contrast scans were able to determine patients’ treatment eligibility within and beyond the treatment window. 

They went on to explain that they observed wide variability in EIS in the studies they included in their research and, therefore, cannot be used to directly establish OTI. However, they believe that when considered together, the associations they observed between OTI and EIS on imaging are valuable for estimating OTI when it is unknown and when advanced imaging is not an option. 

The study abstract can be viewed here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.